NASDAQ:BIB ProShares Ultra Nasdaq Biotechnology (BIB) Price, Holdings, & News → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free BIB Stock Alerts $57.54 -0.55 (-0.95%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$57.52▼$58.4250-Day Range$54.78▼$62.2652-Week Range$40.10▼$62.45Volume34,738 shsAverage Volume43,230 shsMarket Capitalization$92.06 millionAssets Under Management$97.07 millionDividend Yield0.12%Net Expense Ratio0.95% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get ProShares Ultra Nasdaq Biotechnology alerts: Email Address About ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Read More BIB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIB ETF News HeadlinesMarch 28, 2024 | americanbankingnews.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Below Fifty Day Moving Average of $57.70March 25, 2024 | investorplace.comWall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy RichMarch 29, 2024 | DTI (Ad)the most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.March 22, 2024 | msn.comProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0403February 22, 2024 | investorplace.com3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024December 20, 2023 | msn.comProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0383December 15, 2023 | insidermonkey.com5 Most Promising Biotech Stocks to Buy According to AnalystsOctober 29, 2023 | investing.comBIB ETF Stock Price HistoryMarch 29, 2024 | Crypto 101 Media (Ad)Crypto Market Preps For Trillions Worth of Inflows! Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.June 18, 2023 | fool.comProShares Trust - ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB)See More Headlines Receive BIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerProShares Fund NameProShares Ultra Nasdaq Biotechnology Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BIB Inception Date4/6/2010 Fund ManagerMichael Neches, Tarak Dave Webwww.proshares.com Phone+1-240-4976400Fund Focus Asset ClassEquity BenchmarkNasdaq Biotech Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings330 Fund Statistics Assets Under Management$97.07 million Average Daily Volume$50,229.20 Discount/Premium0.14% Leveraged2.00 Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume21 Put Options11 Call Options10 Short Interest55,700 shs Miscellaneous Outstanding Shares1,600,000Beta1.63 Creation Unit50,000 Creation Fee$250.00 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. ProShares Ultra Nasdaq Biotechnology ExpensesTypeBIBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.75%0.57%0.54%0.48%0.51%Other Expenses0.33%0.40%0.54%0.32%0.58%Total Expense1.08%0.72%0.70%0.57%0.70%Fee Waiver-0.13%-0.53%-0.54%-0.20%-0.56%Net Expense0.95%0.61%0.60%0.54%0.58% ProShares Ultra Nasdaq Biotechnology (BIB) Holdings & ExposureTop 10 BIB HoldingsNASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGHolding Weight: 47.36%NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAHolding Weight: 32.88%NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAHolding Weight: 16.22%NASDAQ BIO INDEX SWAP BNPHolding Weight: 14.52%NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEHolding Weight: 7.46%Amgen(NASDAQ:AMGN)Holding Weight: 6.76%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 6.30%Gilead Sciences(NASDAQ:GILD)Holding Weight: 6.27%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 5.94%NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLCHolding Weight: 3.09%BIB Sector ExposureBIB Industry ExposureFull Holdings Details Similar ETFsInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHPrincipal Healthcare Innovators ETFNASDAQ:BTECInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHHorizon Kinetics Medical ETFNASDAQ:MEDXInstitutional OwnershipClarity Capital Partners LLCBought 3,530 shares on 2/20/2024Ownership: 0.221%Citadel Advisors LLCSold 3,800 shares on 2/15/2024Ownership: 0.000%Cassaday & Co Wealth Management LLCSold 29,415 shares on 2/14/2024Ownership: 0.281%Tower Research Capital LLC TRC Sold 5,015 shares on 2/13/2024Ownership: 0.090%Cassaday & Co Wealth Management LLCSold 29,415 shares on 2/9/2024Ownership: 0.281%View All Institutional Transactions BIB ETF - Frequently Asked Questions How have BIB shares performed in 2024? ProShares Ultra Nasdaq Biotechnology's stock was trading at $57.05 at the start of the year. Since then, BIB stock has increased by 0.9% and is now trading at $57.54. View the best growth stocks for 2024 here. Are investors shorting ProShares Ultra Nasdaq Biotechnology? ProShares Ultra Nasdaq Biotechnology saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 55,700 shares, an increase of 98.2% from the February 29th total of 28,100 shares. Based on an average daily volume of 41,800 shares, the short-interest ratio is currently 1.3 days. View ProShares Ultra Nasdaq Biotechnology's Short Interest. How often does ProShares Ultra Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares Ultra Nasdaq Biotechnology? ProShares Ultra Nasdaq Biotechnology announced a dividend on Tuesday, March 19th. Investors of record on Thursday, March 21st will be given a dividend of $0.0403 per share on Wednesday, March 27th. The ex-dividend date is Wednesday, March 20th. Read our dividend analysis for BIB. What does BIB invest in? ProShares Ultra Nasdaq Biotechnology is a equity fund issued by ProShares. BIB focuses on health care investments and follows the Nasdaq Biotech Index. The fund's investments total to approximately $97.07 million assets under management. What stocks does ProShares Ultra Nasdaq Biotechnology hold? BIB invests in 330 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Moderna (MRNA), AstraZeneca (AZN), Biogen (BIIB), Seagen (SGEN), Illumina (ILMN) and Alnylam Pharmaceuticals (ALNY). What is the management fee for ProShares Ultra Nasdaq Biotechnology? ProShares Ultra Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 0.33%. However, BIB has a fee waiver of -0.13% to reimburse the expenses. The net expense ratio for BIB is 0.95%. What other stocks do shareholders of ProShares Ultra Nasdaq Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra Nasdaq Biotechnology investors own include Walt Disney (DIS), Gilead Sciences (GILD), Micron Technology (MU), NVIDIA (NVDA), Starbucks (SBUX), Advanced Micro Devices (amd), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Visa (V). Who are ProShares Ultra Nasdaq Biotechnology's major shareholders? ProShares Ultra Nasdaq Biotechnology's stock is owned by a number of institutional and retail investors. Top institutional investors include IMC Chicago LLC (2.67%), Capital Investment Advisors LLC (0.69%), Toth Financial Advisory Corp (0.70%), Cassaday & Co Wealth Management LLC (0.28%), Cassaday & Co Wealth Management LLC (0.28%) and Palumbo Wealth Management LLC (0.25%). How do I buy shares of ProShares Ultra Nasdaq Biotechnology? Shares of BIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BIB) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.